Riddhi Shah

Biography:

Riddhi Shah is a motivated research professional with 13+ years of experience in translational cancer biology at Memorial Sloan Kettering Cancer Center. Her expertise includes preclinical models (transgenic and PDX), mammalian cell culture, CRISPR/Cas9 editing, and nanoparticle-based drug delivery for targeted protein degradation in liver and brain tumor models. She has a proven track record of publications in high-impact journals, contributions to awarded research grants, and work presentations at national retreats. Riddhi is skilled in mentoring, managing laboratory operations, and ensuring regulatory compliance (IACUC and IBC), and is recognized for her meticulous attention to detail, ability to drive multiple projects to completion, and strong collaborative and communication skills.